BerandaDNA • NYSE
add
Ginkgo Bioworks Holdings Inc
$9,55
Setelah Jam Perdagangan Normal:(0,11%)+0,010
$9,56
Tutup: 16 Jan, 19.56.40 GMT-5 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$9,58
Rentang hari
$9,55 - $10,42
Rentang tahun
$5,00 - $17,58
Kapitalisasi pasar
549,99Â jt USD
Volume Rata-Rata
979,29Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NYSE
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 38,84Â jt | -56,39% |
Biaya operasional | 114,31Â jt | -11,59% |
Penghasilan bersih | -80,76Â jt | -43,18% |
Margin laba bersih | -207,93 | -228,28% |
Penghasilan per saham | — | — |
EBITDA | -88,10Â jt | -82,09% |
Tarif pajak efektif | 0,00% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 461,86Â jt | -25,05% |
Total aset | 1,19Â M | -19,70% |
Total liabilitas | 629,38Â jt | -7,84% |
Total ekuitas | 559,78 jt | — |
Saham yang beredar | 56,84 jt | — |
Harga terhadap nilai buku | 0,97 | — |
Tingkat pengembalian aset | -18,24% | — |
Tingkat pengembalian modal | -21,80% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -80,76Â jt | -43,18% |
Kas dari operasi | -31,61Â jt | 69,46% |
Kas dari investasi | -72,82Â jt | -613,88% |
Kas dari pembiayaan | 9,94Â jt | 2.237,20% |
Perubahan kas bersih | -94,39Â jt | 17,35% |
Arus kas bebas | 514,00Â rb | 100,83% |
Tentang
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Didirikan
2008
Kantor pusat
Situs
Karyawan
834
